Innovative Regenerative Tech Jellagen specializes in marine-sourced Collagen Type Zero, which is at the forefront of regenerative medical research and next-generation treatments, presenting opportunities for biotech and healthcare companies seeking advanced biomaterials.
Strategic Collaborations Recent partnerships with Royal Biologics and Alta Bioscience highlight Jellagen’s active engagement with key industry players, opening potential channels for joint product development and research collaborations.
Recognized Industry Presence Being a finalist at the OBN Awards 2025 positions Jellagen as a credible and innovative player, making it attractive for investors and organizations looking to support breakthrough biotechnologies.
Funding and Growth With $10 million in funding and ongoing technological development, Jellagen is suitable for engagement with investors, grant programs, or corporate partners interested in cutting-edge regenerative solutions.
Market Expansion Potential Jellagen’s focus on developing jellyfish-inspired regenerative medicine presents opportunities to expand into medical device, tissue engineering, and biotech markets actively seeking novel biological materials.
Jellagen uses 8 technology products and services including Google Ads, Google Cloud, AOS, and more. Explore Jellagen's tech stack below.
| Jellagen Email Formats | Percentage |
| First.Last@jellagen.co.uk | 83% |
| First@jellagen.co.uk | 11% |
| FL@jellagen.co.uk | 3% |
| Last@jellagen.co.uk | 3% |
Biotechnology ResearchWales, United Kingdom11-50 Employees
Our jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next generation treatments and supporting current and future scientific research. At the heart of our products is marine-sourced Collagen Type 0, an evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications.
Company Overview
Media & News
Funding & FinancialsJellagen has raised a total of $10M of funding over 3 rounds. Their latest funding round was raised on Apr 01, 2020 in the amount of $2.4Mas a seed.
Jellagen's revenue is estimated to be in the range of $1M
Funding & FinancialsJellagen has raised a total of $10M of funding over 3 rounds. Their latest funding round was raised on Apr 01, 2020 in the amount of $2.4Mas a seed.
Jellagen's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com